Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Preventing strep, and stopping it coming back

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Group A strep spreads through respiratory droplets and direct contact with saliva or secretions. It moves fast in households, classrooms, dormitories and teams.

No vaccine exists, which makes the ordinary measures the whole of prevention. Some of what gets recommended alongside them has less behind it than it appears.

Related pages: Strep throat · Sore throat (pharyngitis)

The bottom line

What we know
  • Group A strep spreads by droplets and direct contact.
  • No licensed vaccine is currently available.
  • Untreated people remain contagious for two to three weeks.
  • Antibiotic treatment sharply reduces contagiousness.
What is still open
  • Whether a vaccine will become available, with candidates in development.
  • How much household measures reduce transmission, which is hard to measure.

The story, step by step

  1. 1. How it spreads ()
  2. 2. What works ()
  3. 3. What is oversold ()
  4. 4. Breaking the cycle ()
  5. 5. A vaccine ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Droplets and saliva

Review of many studies

What happens

The routes, which determine what helps.

What the research shows

  • Respiratory droplets from coughing, sneezing, talking and singing, mostly over short distances indoors.
  • Direct contact with saliva or nasal secretions, including shared drinks, bottles, utensils, towels and lip products.
  • Contact with infected skin sores, since the same bacteria cause impetigo and other skin infections.
  • Rarely, through food that has been contaminated and improperly stored, which has caused outbreaks.
  • Crowded indoor settings concentrate it: households, classrooms, childcare, dormitories, military barracks and sports teams.

Why it matters

It is a close-contact infection. Distance and not sharing saliva do more than anything else.

What's still uncertain

  • The relative contribution of each route is not precisely known.

Read more

Next: What works

Part 2 of 5

The measures with a rationale

Review of many studies

What happens

Prevention in order of how much it is likely to do.

What the research shows

  • Treating people who have it: antibiotics sharply reduce contagiousness within 12 to 24 hours, compared with two to three weeks untreated.
  • Not sharing drinks, bottles, utensils, towels, toothbrushes or lip balm.
  • Covering coughs and sneezes with a tissue or elbow rather than a hand.
  • Handwashing with soap and water for 20 seconds, or alcohol sanitizer when that is not available.
  • Staying home while symptomatic and until the return criteria are met.
  • Keeping cuts and grazes clean and covered, and not sharing towels or bedding with someone who has skin sores.

Why it matters

The highest-impact prevention is treating the person who has it. Everything else is secondary to that.

What's still uncertain

  • Household measures are sensible and hard to quantify.

Read more

Next: What is oversold

Part 3 of 5

Honest ratings

Review of many studies

What happens

Measures that get recommended with more confidence than the evidence supports.

What the research shows

  • Daily disinfection of doorknobs, light switches and remotes. Group A strep spreads mainly by droplets and direct contact, so surfaces play a minor role.
  • Toothbrush replacement after starting antibiotics. Widely advised, weak evidence, cheap and harmless, so reasonable rather than necessary.
  • Vitamin C, vitamin D and zinc for preventing strep. No evidence supports them for this. Correcting an actual deficiency is a different matter.
  • Immune-boosting supplements and throat sprays sold for prevention: no evidence.
  • Avoiding cold weather or wet hair. Strep is a bacterium passed between people, not caught from temperature.
  • Things that do have a rationale: not smoking or vaping, which irritates the throat lining, treating nasal allergy that causes mouth breathing, and keeping indoor air from being very dry.

Why it matters

Worth knowing which of the usual advice is doing work. Not sharing drinks is; disinfecting the remote control mostly is not.

What's still uncertain

  • Absence of evidence for these measures is not the same as evidence they do nothing.

Read more

Next: Breaking the cycle

Part 4 of 5

Household reinfection

Review of many studies

What happens

When it keeps going round a family.

What the research shows

  • Make sure the person with it completes the full course. Partial treatment is the most common reason it returns.
  • Separate toothbrushes so bristles do not touch, and stop the sharing of drinks that households do without noticing.
  • Treat anyone who develops symptoms promptly rather than waiting to see.
  • Testing and treating well family members is not recommended, because carriage is common and treating it achieves little.
  • If episodes keep cycling through a household, a clinician may consider carriage, an untreated contact, or in some cases a different antibiotic approach.
  • Pets do not carry group A strep. The dog is not the reservoir, despite the persistent belief.

Why it matters

The most common cause of a household cycle is an incomplete course, not a hidden reservoir.

What's still uncertain

  • Managing persistent household cycles has little formal evidence behind it.

Read more

Next: A vaccine

Part 5 of 5

Why there isn't one

Review of many studies

What happens

The state of strep vaccine development.

What the research shows

  • No licensed group A strep vaccine exists anywhere.
  • The main historical obstacle was safety: early vaccines in the 1960s raised concerns about provoking rheumatic fever, which led to a long regulatory pause in the United States.
  • The bacterium also has over 200 strain types distinguished by a surface protein, so a vaccine must either cover many of them or target something shared.
  • Current candidates include multi-strain vaccines and ones targeting conserved regions or other bacterial components, and several are in clinical trials.
  • The potential impact is large, mostly in countries where rheumatic heart disease remains common, and the World Health Organization has set development as a priority.
  • Until then, prevention is behavioural and treatment is the main tool.

Why it matters

A vaccine would matter most in the places where rheumatic heart disease is still common, which is where strep does the most damage.

What's still uncertain

  • No candidate is close to licensure, and timelines are uncertain.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.